These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24831653)

  • 1. Population pharmacokinetics of valproic acid in adult Chinese epileptic patients and its application in an individualized dosage regimen.
    Lin WW; Jiao Z; Wang CL; Wang HY; Ma CL; Huang PF; Guo XZ; Liu YW
    Ther Drug Monit; 2015 Feb; 37(1):76-83. PubMed ID: 24831653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population pharmacokinetics of lamotrigine co-administered with valproic acid in Chinese epileptic children using nonlinear mixed effects modeling.
    Xu S; Liu L; Chen Y; Liu M; Lu T; Wang H; Liu S; Zhao M; Zhao L
    Eur J Clin Pharmacol; 2018 May; 74(5):583-591. PubMed ID: 29340733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of valproic acid in epileptic children: Effects of clinical and genetic factors.
    Xu S; Chen Y; Zhao M; Guo Y; Wang Z; Zhao L
    Eur J Pharm Sci; 2018 Sep; 122():170-178. PubMed ID: 29981400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation.
    Ding J; Wang Y; Lin W; Wang C; Zhao L; Li X; Zhao Z; Miao L; Jiao Z
    Clin Pharmacokinet; 2015 Mar; 54(3):305-17. PubMed ID: 25388986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetics of valproate in Chinese children with epilepsy.
    Jiang DC; Wang L; Wang YQ; Li L; Lu W; Bai XR
    Acta Pharmacol Sin; 2007 Oct; 28(10):1677-84. PubMed ID: 17883957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonlinear mixed effects modelling approach in investigating phenobarbital pharmacokinetic interactions in epileptic patients.
    Vučićević K; Jovanović M; Golubović B; Kovačević SV; Miljković B; Martinović Ž; Prostran M
    Eur J Clin Pharmacol; 2015 Feb; 71(2):183-90. PubMed ID: 25380628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictability of individualized dosage regimens of carbamazepine and valproate mono- and combination therapy.
    Bondareva IB; Jelliffe RW; Andreeva OV; Bondareva KI
    J Clin Pharm Ther; 2011 Oct; 36(5):625-36. PubMed ID: 21062333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetic modeling of steady state clearance of carbamazepine and its epoxide metabolite from sparse routine clinical data.
    Jiao Z; Shi XJ; Zhao ZG; Zhong MK
    J Clin Pharm Ther; 2004 Jun; 29(3):247-56. PubMed ID: 15153086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing valproate pharmacokinetics in children and adults.
    Jankovic SM; Milovanovic JR; Jankovic S
    Int J Clin Pharmacol Ther; 2010 Nov; 48(11):767-75. PubMed ID: 20979937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population estimation of valproic acid clearance in adult patients using routine clinical pharmacokinetic data.
    Blanco-Serrano B; Otero MJ; Santos-Buelga D; García-Sánchez MJ; Serrano J; Domínguez-Gil A
    Biopharm Drug Dispos; 1999 Jul; 20(5):233-40. PubMed ID: 10594867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of oxcarbazepine active metabolite in Chinese paediatric epilepsy patients and its application in individualised dosage regimens.
    Lin WW; Li XW; Jiao Z; Zhang J; Rao X; Zeng DY; Lin XH; Wang CL
    Eur J Clin Pharmacol; 2019 Mar; 75(3):381-392. PubMed ID: 30456415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of the Optimal Concentration of Valproic Acid in Patients with Epilepsy: A Population Pharmacokinetic-Pharmacodynamic Analysis.
    Nakashima H; Oniki K; Nishimura M; Ogusu N; Shimomasuda M; Ono T; Matsuda K; Yasui-Furukori N; Nakagawa K; Ishitsu T; Saruwatari J
    PLoS One; 2015; 10(10):e0141266. PubMed ID: 26484865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic modelling of valproic acid from routine clinical data in Egyptian epileptic patients.
    EL Desoky ES; Fuseau E; EL Din Amry S; Cosson V
    Eur J Clin Pharmacol; 2004 Jan; 59(11):783-90. PubMed ID: 14673555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproate population pharmacokinetics in children.
    Serrano BB; García Sánchez MJ; Otero MJ; Buelga DS; Serrano J; Domínguez-Gil A
    J Clin Pharm Ther; 1999 Feb; 24(1):73-80. PubMed ID: 10319910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular Filtration Rate Is a Major Predictor of Clearance of Oxcarbazepine Active Metabolite in Adult Chinese Epileptic Patients: A Population Pharmacokinetic Analysis.
    Lin WW; Wang CL; Jiao Z; Yu XL; Zhang J; Zhang WB; Lin RF; Lin S; Lin XH
    Ther Drug Monit; 2019 Oct; 41(5):665-673. PubMed ID: 31033858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of valproic acid in adult Chinese patients with bipolar disorder.
    Zang YN; Guo W; Niu MX; Bao S; Wang Q; Wang Y; Dong F; Li AN; Ruan CJ
    Eur J Clin Pharmacol; 2022 Mar; 78(3):405-418. PubMed ID: 34854947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug treatment of epilepsy in elderly people: focus on valproic Acid.
    Stephen LJ
    Drugs Aging; 2003; 20(2):141-52. PubMed ID: 12534314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A population pharmacokinetic model taking into account protein binding for the sustained-release granule formulation of valproic acid in children with epilepsy.
    Rodrigues C; Chhun S; Chiron C; Dulac O; Rey E; Pons G; Jullien V
    Eur J Clin Pharmacol; 2018 Jun; 74(6):793-803. PubMed ID: 29564480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics of unbound valproic acid in pediatric epilepsy patients in China: a protein binding model.
    Gu X; Zhu M; Sheng C; Yu S; Peng Q; Ma M; Hu Y; Li Z; Jiao Z; Zhou B
    Eur J Clin Pharmacol; 2021 Jul; 77(7):999-1009. PubMed ID: 33423079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic modeling of valproate from clinical data in Serbian epileptic patients.
    Jankovic SM; Milovanovic JR
    Methods Find Exp Clin Pharmacol; 2007 Dec; 29(10):673-9. PubMed ID: 18200330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.